Shenzhen - Delayed Quote CNY
Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ)
24.33
+0.05
+(0.21%)
At close: May 30 at 3:04:51 PM GMT+8
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Kailie Liu | President & Non-Independent Director | -- | -- | 1964 |
Ms. Xiaomei Yao | Financial Director | -- | -- | 1970 |
Ms. Jianqin Xiao | Vice President of Operations | -- | -- | 1969 |
Mr. Weiwu Chen | Chief Scientific Officer | -- | -- | 1972 |
Mr. Zhiqiang Wang | VP & Director of Administration Department | -- | -- | 1960 |
Ms. Ping Feng | VP & Secretary of the Board of Directors | -- | -- | 1970 |
Mr. Jun Li | Vice President | -- | -- | 1975 |
Ms. Min Zhao | Vice President | -- | -- | 1972 |
Mr. Haijian Xia | Vice President | -- | -- | 1975 |
Tibet Cheezheng Tibetan Medicine Co., Ltd.
No. 2, Deji Road
Bayi District Linzhi City
Nyingchi, 860000
China
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Tibet Cheezheng Tibetan Medicine Co., Ltd. engages in the research, development, production, and sale of Tibetan medicines in China. The company also provides plasters and ointments. Its products are used in areas of orthopedics, neurology, dermatology, gynecology, pediatrics, respiratory, gastroenterology, cardiovascular, and cerebrovascular sectors. The company was founded in 1995 and is based in Nyingchi, China. Tibet Cheezheng Tibetan Medicine Co., Ltd. is a subsidiary of Gansu Qizheng Industry Group Co., Ltd.
Corporate Governance
Tibet Cheezheng Tibetan Medicine Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
January 24, 2025 at 12:00 AM UTC
Ex-Dividend Date
Related Tickers
394800.KQ 3billion
6,540.00
-0.46%
603392.SS Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
69.30
-0.20%
688331.SS RemeGen Co., Ltd.
58.99
+0.24%
087010.KQ Peptron, Inc.
230,000.00
-1.08%
476040.KQ ORGANOIDSCIENCES
34,200.00
-6.30%
2162.HK Keymed Biosciences Inc.
44.100
0.00%
1952.HK Everest Medicines Limited
42.800
-3.06%
6660.HK AIM Vaccine Co., Ltd.
3.630
-3.72%
2171.HK CARsgen Therapeutics Holdings Limited
20.100
-1.23%
9969.HK InnoCare Pharma Limited
11.260
0.00%